Skip to search formSkip to main contentSkip to account menu

delamanid

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
SETTING Many drugs with potential QT prolongation effects (QT drugs) have already been used for decades in patients with… 
Review
2016
Review
2016
Otsuka has been engaged in anti-tuberculosis drug development efforts for over 30 years, and is the leading private sector funder… 
Review
2015
Review
2015
Out of a handful of new drugs currently in clinical trials for the treatment of tuberculosis, delamanid, a nitro-dihydro… 
Review
2015
Review
2015
Introduction: The limited availability of effective drugs causes difficulties in the management of multidrug-resistant… 
Review
2014
Review
2014
Purpose of review Recent advances in the development of new drugs and regimens provide hope that well tolerated, effective, and…